# Indomethacin Eyedrops Compared With Ketorolac Eyedrops for Ocular Inflammation Following Cataract Surgery

> **NCT00904904** · PHASE4 · COMPLETED · sponsor: **Bausch & Lomb Incorporated** · enrollment: 120 (actual)

## Conditions studied

- Cataract
- Inflammation

## Interventions

- **DRUG:** Indomethacin ophthalmic solution
- **DRUG:** Ketorolac Ophthalmic Solution

## Key facts

- **NCT ID:** NCT00904904
- **Lead sponsor:** Bausch & Lomb Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2009-06
- **Final completion:** 2009-09
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2012-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00904904

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00904904, "Indomethacin Eyedrops Compared With Ketorolac Eyedrops for Ocular Inflammation Following Cataract Surgery". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00904904. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*